Major drugmakers are filing lawsuits against the HHS and HRSA to try to resuscitate plans to issue hospitals rebates instead ...

Despite growing revenues, most major insurers saw their profits from offering health plans shrink in the third quarter as ...

Regulators’ assessment of customer support centers has spurred recent lawsuits from insurers. But the metric “is going to ...

Donald Trump’s first term as president was characterized by significant turbulence for government healthcare programs. Here’s ...

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug ...

Kaiser said it would institute cost-cutting measures in response to the lackluster financial results, but didn’t detail ...

Do to others what you would want done to yourself,” Medicaid director Daniel Tsai said Thursday when asked about advice for ...

Saum Sutaria doesn't think the ACA marketplace is going anywhere under President-elect Donald Trump, noting beneficiaries are ...

The Franklin, Tennessee-based operator has not purchased a hospital in years. That may soon change as CHS' margins improve.

The drug distributor will buy a majority stake in gastroenterology practice management group GI Alliance and purchase ...

The nomination of a prominent vaccine skeptic to the head of the nation’s largest healthcare program is expected to alarm ...

Centene President Ken Fasola is retiring, according to a securities filing on Tuesday. Fasola will leave Centene by next July ...